T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients

Neurology

Volumn 81, Issue 9, 2013, Pages 784-792

  Balint, Bettina ^a   Haas, Jürgen ^a   Schwarz, Alexander ^a   Jarius, Sven ^a   Fürwentsches, Alexandra ^b   Engelhardt, Kathrin ^b   Bussmann, Cornelia ^b   Ebinger, Friedrich ^c   Fritzsching, Benedikt ^b   Paul, Friedemann ^d   Seidel, Ulrich ^e   Vlaho, Stefan ^f   Huppke, Peter ^g   Gärtner, Jutta ^g   Wildemann, Brigitte ^a  

^a Airway Inflammation Translational Lung Research Center   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c St Vincenz Hospital   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f GOETHE UNIVERSITY   (Germany)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT;

ADOLESCENT; ADULT; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MALE; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; T LYMPHOCYTE;

ADULT; AGE FACTORS; CHILD; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOLOGIC MEMORY; MALE; MULTIPLE SCLEROSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84884479311     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a2ce0e     Document Type: Article

References (34)

1. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007;6: 887-902.
2. Boiko A, Vorobeychik G, Paty D, et al. Early onset multiple sclerosis: a longitudinal study. Neurology 2002;59: 1006-1010.
3. Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007;356:2603-2613.
4. Vargas-Lowy D, Chitnis T. Pathogenesis of pediatric multiple sclerosis. J Child Neurol 2012;27:1394-1407.
5. Hug A, Korporal M, Schröder I, et al. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol 2003;171: 432-437.
6. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD41CD251 regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971-979.
7. Haas J, Hug A, Viehöver A, et al. Reduced suppressive effect of CD41CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 2005;35:3343-3352.
8. Haas J, Fritzsching B, Trübswetter P, et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 2007;179:1322-1330.
9. Duszczyszyn DA, Williams JL, Mason H, Lapierre Y, Antel J, Haegert DG. Thymic involution and proliferative T-cell responses in multiple sclerosis. J Neuroimmunol 2010;221:73-80.
10. Haas J, Korporal M, Schwarz A, Balint B, Wildemann B. The interleukin-7 receptor a chain contributes to altered homeostasis of regulatory T cells in multiple sclerosis. Eur J Immunol 2011;41:845-853.
11. Fritzsching B, Oberle N, Pauly E, et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 2006;108: 3371-3378.
12. Hoffmann P, Eder R, Boeld TJ, et al. Only the CD45RA1 subpopulation of CD41CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006;108:4260-4267.
13. Duszczyszyn DA, Beck JD, Antel J, et al. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms. Clin Exp Immunol 2006;143:305-313.
14. Haegert DG. Multiple sclerosis: a disorder of altered T-cell homeostasis. Mult Scler Int 2011;2011:461304.
15. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 2005;58:840-846.
16. Chitnis T, Tenembaum S, Banwell B, et al. Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler 2012;18:116-127.
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
18. Korporal M, Haas J, Balint B, et al. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells. Arch Neurol 2008;65:1434-1439.
19. Haas J, Korporal M, Balint B, Fritzsching B, Schwarz A, Wildemann B. Glatiramer acetate improves regulatory Tcell function by expansion of naive CD4 (1) CD25 (1) FOXP3 (1) CD31 (1) T-cells in patients with multiple sclerosis. J Neuroimmunol 2009;216:113-117.
20. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD41 T cells expressing the FoxP3 transcription factor. Immunity 2009;30:899-911.
21. Baccala R, Theofilopoulos AN. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol 2005;26:5-8.
22. Gerli R, Paganelli R, Cossarizza A, et al. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 1999;103:865-872.
23. Halnon NJ, Cooper P, Chen DY, Boechat MI, Uittenbogaart CH. Immune dysregulation after cardiothoracic surgery and incidental thymectomy: maintenance of regulatory T cells despite impaired thymopoiesis. Clin Dev Immunol 2011;2011:915864.
24. La Gruta NL, Driel IR, Gleeson PA. Peripheral T cell expansion in lymphopenic mice results in a restricted T cell repertoire. Eur J Immunol 2000;30:3380-3386.
25. Chen X, Fang L, Song S, Guo TB, Liu A, Zhang JZ. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp31 regulatory T cells through IL-7 signaling pathway. J Immunol 2009;183:6135-6144.
26. Thewissen M, Linsen L, Somers V, Geusens P, Raus J, Stinissen P. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Ann NY Acad Sci 2005;1051:255-262.
27. Tsaknaridis L, Spencer L, Culbertson N, et al. Functional assay for human CD41CD251 Treg cells reveals an agedependent loss of suppressive activity. J Neurosci Res 2003;74:296-308.
28. Schatorjé EJ, Gemen EF, Driessen GJ, Leuvenink J, van Hout RW, de Vries E. Paediatric reference values for the peripheral T cell compartment. Scand J Immunol 2012; 75:436-444.
29. Elong Ngono A, Pettré S, Salou M, et al. Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients. Clin Immunol 2012;144:117-126.
30. Correale J, Tenembaum SN. Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis. Mult Scler 2006;12:412-420.
31. Banwell B, Bar-Or A, Cheung R, et al. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes. Ann Neurol 2008;63:98-111.
32. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4 (1) CD25 (1) T-cells from patients with type 1 diabetes. Diabetes 2005;54:92-99.
33. Venken K, Hellings N, Broekmans T, Hensen K, Rummens JL, Stinissen P. Natural naive CD41CD251 CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J Immunol 2008;180:6411-6420.
34. de Andrés C, Aristimuño C, de Las Heras V, et al. Interferon beta-1a therapy enhances CD41 regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J Neuroimmunol 2007;182:204-211.